Pathogenic sequence variant and microdeletion affecting HMGA2 in Silver–Russell syndrome: case reports and literature review

Kaori Yamoto,Hirotomo Saitsu,Yumiko Ohkubo,Masayo Kagami,Tsutomu Ogata
DOI: https://doi.org/10.1186/s13148-024-01688-w
2024-06-08
Clinical Epigenetics
Abstract:Silver–Russell syndrome (SRS) is a representative imprinting disorder characterized by pre- and postnatal growth failure. We encountered two Japanese SRS cases with a de novo pathogenic frameshift variant of HMGA2 (NM_003483.6:c.138_141delinsCT, p.(Lys46Asnfs*16)) and a de novo ~ 3.4 Mb microdeletion at 12q14.2–q15 involving HMGA2 , respectively. Furthermore, we compared clinical features in previously reported patients with various genetic conditions leading to compromised IGF2 expression, i.e. , HMGA2 aberrations, PLAG1 aberrations, IGF2 aberrations, and H19 / IGF2 :IG-DMR epimutations (hypomethylations). The results provide further support for HMGA2 being involved in the development of SRS and imply some characteristic features in patients with HMGA2 aberrations.
oncology,genetics & heredity
What problem does this paper attempt to address?